According to the Low Dose Naltrexone home page [LDN],
LDN has been seen to benefit Sjögren's Syndrome,
which is considered to be an autoimmune disease.
See [Zashin2020 🕮 ] [Zashin2019 🕮 ]
Dr. Weyrich has been trained to use Low Dose Naltrexone (LDN) and offers these
protocols as a complement to other therapies;
however at this time Dr. Weyrich has only treated one confirmed case of Sjögren's Syndrome
using LDN; the patient reported significant improvement in symptoms and remains on the
treatment (as of 09/07/2016).
Please see What is Low Dose Naltrexone?
for more information.
[McCulley2018, pp 28, 35, 61, 89, 351-362] reports that Sjögren's syndrome is a
TH1-dominant, systemic,
autoimmune disorder, and proposes an approach to treating this disease, which should be
supervised by a properly trained medical professional.
Dr. Weyrich has considerable interest in this topic, but has
not treated any cases of Sjögren's syndrome
with Immune System Balancing.
Please see What is Immune System Balancing?
for more information.